Brain research shows past experience is invaluable for complex decision making

Researchers funded by the Biotechnology and Biological Sciences Research Council (BBSRC) have shown that past experience really does help when we have to make complex decisions based on uncertain or confusing information. They show that learning from experience actually changes the circuitry in ou...

Lilly to Take Charge to Earnings Related to Pending Federal and State Investigations of Past Practices

Company Will Take $1.415 Billion Charge in Third Quarter 2008 INDIANAPOLIS, Oct. 21 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY ) today announced that it is in advanced discussions to resolve the ongoing investigations led by the U.S. Attorney's Office for the Eastern Dist...

Verathon Inc., Maker of BladderScan(R) and GlideScope(R), Ranks in Deloitte's 2008 Washington State Technology 'Fast 50' for 5th Time in Past 7 Years

BOTHELL, Wash., Sept. 29 /PRNewswire/ -- Verathon Inc. is pleased to announce that it has once again been ranked in the prestigious Technology Fast 50 Program for Washington State, a ranking of the 50 fastest growing technology, media, telecommunications and life sciences companies in the area...

Nanotechnology: Learning from past mistakes

Washington, DC A new expert analysis in Nature Nanotechnology questions whether industry, government and scientists are successfully applying lessons learned from past technologies to ensure the safe and responsible development of emerging nanotechnologies. The study applies the 12 "late ...

Migenix Takes Operational Actions To Extend Cash Past Upcoming Key Milestones

VANCOUVER and SAN DIEGO, May 27 /PRNewswire-FirstCall/ - MIGENIX Inc. (TSX: MGI, OTC: MGIFF), a clinical-stage developer of drugs for infectious diseases, is taking aggressive steps to further reduce expenses to extend its cash runway through the Omigard(TM) Phase III results milestone expecte...

Statement by InterMune, Inc. Regarding Justice Department Action Against Former Employee for Past Conduct

BRISBANE, Calif., March 18 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN ) issued the following statement regarding today's indictment of a former employee in connection with the promotional activities for Actimmune(R) (interferon gamma-1b) during a period that ended in June of 2003...

Information technology past the end of the Earth

So it's 1492. At least that's how we're acting. The grand majesty of the IT industry is huddled in our comfortable little corner of the world. Yeah, we send the occasional skirmish over into the Kingdom of Marketing or Manufacturing or wherever we think "the business" is, but our maps of the worl...

Off-the-grid networking can help you cut past chit-chat

How the notion of networking has changed over the years is a funny thing. When Midwest tech people talked about networking a decade ago, they were mostly talking about reaching out to their friends and colleagues for job opportunities and business development leads. In other words, to most Mid...

Winners of past business plan contests secure funding, credibility

Madison, Wis. - One state initiative aimed at galvanizing the high-tech industry in Wisconsin appears to be having the desired effect. Several emerging technology companies have earned much-needed start-up momentum, and attracted the attention of investors, after submitting winning business pl...

NimbleGen names CFO with capital-raising past

Madison, Wis. - NimbleGen Systems, Inc. , a supplier of DNA microarrays for genome research, has appointed a new chief financial officer with experience managing large entrepreneurial growth companies. David Snyder brings more than 15 years of experience in capital raising, finance, and gener...

DOE awards $377 million in funding for 46 energy frontier research centers

...rces, neutron scattering sources, supercomputing, and other advanced instrumentation, much of it developed with DOE Office of Science support over the past decade, in an effort to lay the scientific groundwork for fundamental advances in solar energy, biofuels, transportation, energy efficiency, electrici...

Growth spurts

...sis nanocrystals with desired physical properties. This will require a much better understanding of colloidal nanocrystal growth mechanisms. While the past two decades have seen tremendous advances in the synthesis of semiconductor, metal and dielectric nanocrystals, these advances have generally been rea...

Knighted Adds Industry Pioneer and Entrepreneur to Senior Management Team

... execution and data collection, joining Knighted is an exciting opportunity representing virtually unlimited potential," said Mr. Wilensky. "Over the past 15 years, Knighted has built arguably the most dynamic software for managing supply chains while processing billions of inventory transactions each ye...

Pharmacyclics, Inc. Rights Offering Oversubscribed

...g statements. Our actual results could differ materially from those projected in the forward-looking statements. Additionally, you should not consider past results to be an indication of our future performance. For a discussion of the risk factors and other factors that may affect our results, please see ...

Cord Blood America Retires $2.53M Obligation

...nge Commission. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. The Company's past performance is not necessarily indicative of its future performance. The Company does not undertake, and the Company specifically disclaims any obliga...

Patent Attorney John Rizvi Speaks at FIME International Medical Expo

...medical products, medical services and medical technology companies. South Florida has seen steady growth in the medical device industry over the past ten years and John Rizvi, a patent attorney who specializes in patenting medical devices, is giving a presentation to educate medical technology compa...

SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2009 FINANCIAL RESULTS

...lsewhere. In addition to the activities regarding the Sweet Enhancers, Senomyx had notable progress in its Bitter Blockers Program during the past quarter. Recent taste tests demonstrated that the Company's bitter blockers can provide statistically significant reductions in the bitterness of a v...

OmniComm Systems Acquires EDC Assets of Leading Phase I Clinical Software Vendor - Logos Technologies, Ltd.

...ing Director. "OmniComm's team of industry professionals was a key factor in our decision making process. We have worked closely with OmniComm in the past with several joint clients and see this as an opportunity to enhance and fully integrate the Logos products with OmniComm's eClinical solutions. Our c...

Global Jatropha Hi-Tech Agricultural Training Programme (JWTP)

... last year's event, and a number of alternative feedstocks emerged over the past year as apart from Jatropha, the training course also includes two other im... last year's event, and a number of alternative feedstocks emerged over the past year as apart from Jatropha, the training course also includes two other im...

China-Biotics, Inc. Applies for Four Patents on Probiotic Formulations

...ent standards for food production throughout China. The officials praised the Company's significant achievements in probiotics applications during the past decade and encouraged management to continue its business expansion efforts. About China-Biotics, Inc. China-Biotics, Inc. ("China-Biot...

Endo Pharmaceuticals Reports Strong Second Quarter 2009 Financial Results

...h, we will be highlighting key milestones and patient successes through the past decade through a variety of external channels. In addition, the Patc...ology, endocrinology and primary care. More information, including this and past press releases of Endo Pharmaceuticals, is available at www.endo.com . ...

First U.K. Stem Cell Awareness Rally to Take Place in Manchester, England on August 9th, 2009

...Association's ( http://www.stemcellaware.com ) seventh awareness rally, past patients, interested physicians, and prospective patients will meet in Manc...ts about the best treatment options available today and provide a forum for past patients to connect with people considering stem cell treatment and to help...

Sunesis Reports Financial Results for the Second Quarter 2009

...an cancer patients are high. Treatment options remain limited following relapse, and overall long-term survival has not changed significantly over the past 40 years, with five-year survival rates at less than 30 percent. About Sunesis Pharmaceuticals Sunesis is a biopharmaceutical compan...

NPL and University of Surrey sign £10m deal

... Memorandum of Understanding with Surrey and affords us the chance to demonstrate real impact from EPRSC funded research into the UK economy. Over the past ten years we have developed knowledge transfer processes and tools as part of the National Measurement Office-sponsored National Measurement System. W...

Zimmer Launches New Medical Education and BioSkills Training Program

...d., July 27 /PRNewswire-FirstCall/ -- Zimmer Holdings, Inc. (NYSE: ZMH ; SWX: ZMH) today announced the launch of the new Zimmer Institute. Over the past year, Zimmer has collaborated with teaching surgeons and subject matter experts to develop a unique model for surgeon and clinician training. Combinin...

Digitas Health Expands Adding Two Key Locations

... Health has experienced increased annual revenue growth of approximately 50 percent in each of the last three years, 14 new client brand wins over the past 12 months, and has received substantial recognition in the form of awards and market eminence. Digitas Health London The Digitas Health Lon...

World Renowned Scientists Gather to Share Latest Information on Answer to Wildlife Reproductive Fertility Control

...hat will determine the research goals for the coming year. SenesTech is grateful to the City of Flagstaff, Arizona for its support during the past seven years. "The City of Flagstaff, through its incubator program at the Northern Arizona Center for Emerging Technologies has allowed us to follow ...

FDA Grants First Authorization of a Commercial 2009 H1N1 Flu Test for use During Pandemic Flu Emergency to Quest Diagnostics' Focus Diagnostics Business

...ive for the 2009 H1N1 influenza virus. By comparison, positivity rates in adults 21 to 40 years of age have averaged approximately 49 percent over the past two months. Adults 41 to 60 years of age have experienced positivity rates of 36 percent, while those 61 to 80 years of age have experienced positivit...

PROLOR Biotech Announces $10 Million Preferred Stock Line From Members of The Frost Group

...sting line of credit agreement with The Frost Group has been terminated. "After working closely with the PROLOR team as chairman over the past two years, I am very pleased to be expanding my investment in the company at this exciting time in its development, together with other members of The...

Junying Yu, Leading Stem Cell Researcher, Joins Cellular Dynamics International

... first to successfully establish human embryonic stem cell lines in 1998 . "It has been an absolute privilege to work with Junying for the past six years at UW, and I am excited to continue the relationship," said Dr. Thomson, CDI's Chief Scientific Officer. "Junying could have gone anywhere, ...

Neogen Reports 16% Increase in Revenues

...tions for the company, and the 69th quarter of the past 74 quarters to show increased revenues as compared...ell-publicized outbreaks of equine botulism in the past year and a focused marketing response contributed ...ncreased notice in the investment community in the past year, as the company was selected for the Russell ...

GeneGo Donates Proprietary Cytokine Pathway Maps to ISICR

...s, etc. The addition of the GeneGo pathways will certainly provide ISICR members with an exceptionally valuable educational tool," said Howard Young, past President ISICR. "We are very pleased to help the ISICR with this contribution," said Julie Bryant, GeneGo's VP of Business Development. "Gen...

Wyeth Announces Stockholder Approval of Pfizer Merger at 2009 Annual Meeting

...to expect the transaction to close at the end of the third quarter or during the fourth quarter of this year. Summarizing highlights from the past year, Mr. Poussot stated: "The strength and diversity of the Company we have built enabled us to achieve strong 2008 financial results, bring importan...

Big Pharma to Big Biopharma: Frost & Sullivan Examines the Latest M&A Trends and Opportunities

... 2009. (Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO ) "The real intention behind these mergers remains a question, as past mergers have not yielded substantial value addition in terms of R&D productivity," says Frost & Sullivan Senior Research Analyst Ranjith Gopin...

Karl Strauss and GreenHouse Partner to Create Alternative Fuel from Beer Waste

...y characteristic of today’s era of social responsibility. “Karl Strauss has been an integral part of San Diego’s growth over the past two decades,” said Chris Cramer, Karl Strauss CEO and co-founder. “We have grown as a brewery, we have realized our expanding footprint on...

Pharmacyclics Announces Subscription Price for Rights Offering

...g statements. Our actual results could differ materially from those projected in the forward-looking statements. Additionally, you should not consider past results to be an indication of our future performance. For a discussion of the risk factors and other factors that may affect our results, please see ...

NeoStem Featured on CBS2 News; Success of Licensed Stem Cell Treatments Shown for Arthritis and Orthopedic Problems; Procedure to be Used by NeoStem Affiliate in China

... cell expansion." As Dr. Gomez pointed out, adult stem cell therapies are being successfully applied in an increasing number of medical areas. In the past few months, NeoStem has obtained licenses to adult stem cell applications in the therapeutic areas of wound-healing and skin rejuvenation as well as o...

Brain Monitor Eliminates Need for Routine Oxygen With Propofol - Friedberg's Triad Unveiled

...gery anesthesia in no small part due to the tireless efforts of Dr. Friedberg in promoting the use of his PK (or propofol ketamine) anesthesia for the past 17 years. After nearly two decades of providing PK anesthesia for cosmetic surgery for more than 100 different surgeons, there is no question th...

Instrumentation Laboratory to Announce 'Passion & Results' Award Winners

... established to honor healthcare providers who have demonstrated true passion for their profession, resulting in improved patient care. For the past year, IL has embarked on a coordinated global promotional campaign to encourage nominations -- resulting in a rich collection of compelling stories fr...

Accuri Cytometers Completes $4 Million Series D Financing

...ance its investments across three principal business sectors: Therapeutics, Life Science Tools & Diagnostics, and BioEnergy/Cleantech. During the past two decades Flagship's principals have been involved as founders or investors in many highly successful ventures including: Adnexus Therapeutics, Aler...